Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a cash flow conversion efficiency ratio of -0.064x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.37 Million) by net assets ($287.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kestra Medical Technologies, Ltd. Common net asset quality index to measure how much of total assets are equity-financed.
Kestra Medical Technologies, Ltd. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Kestra Medical Technologies, Ltd. Common cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Adriatic Metals Plc
F:3FN
|
-0.035x |
|
Capital Clean Energy Carriers Corp.
NASDAQ:CCEC
|
0.040x |
|
Berkshire Hills Bancorp Inc
NYSE:BHLB
|
0.032x |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
0.022x |
|
Teva Pharmaceutical Industries Ltd
TA:TEVA
|
0.038x |
|
Xpel Inc
NASDAQ:XPEL
|
0.121x |
|
Bolsa Mexicana de Valores S.A.B. de C.V
MX:BOLSAA
|
0.042x |
|
Faraday Technology Corp
TW:3035
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Kestra Medical Technologies, Ltd. Common (KMTS) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.41 Million | $-77.61 Million | -0.378x | -209.52% |
| 2024-04-30 | $-209.38 Million | $-72.23 Million | 0.345x | -41.75% |
| 2023-04-30 | $-117.58 Million | $-69.64 Million | 0.592x | +103.50% |
| 2021-04-30 | $1.77 Million | $-29.89 Million | -16.928x | -115.53% |
| 2020-04-30 | $3.86 Million | $-30.29 Million | -7.854x | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more